Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,413.00
Bid: 2,413.00
Ask: 2,415.00
Change: -14.00 (-0.58%)
Spread: 2.00 (0.083%)
Open: 2,417.00
High: 2,420.00
Low: 2,408.00
Prev. Close: 2,427.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

4 Oct 2005 07:00

British American Tobacco PLC04 October 2005 For immediate release: Tuesday 4 October 2005 British American Tobacco agrees sale of stake in B.A.R Honda British American Tobacco today confirms that it has agreed the sale of its 55per cent stake in B.A.R Honda to Honda Motor Co. Ltd. The sale is expected totake effect by 31 December 2005. With Honda's existing 45 per centshareholding, purchased in January 2005, this transaction will give Hondacomplete ownership of the team. The B.A.R Honda team (then British American Racing) was established by BritishAmerican Tobacco in 1997. After a challenging first few years it rose to secondplace in the 2004 FIA Constructors' World Championship, one of the quickestascents of a F1 team. British American Tobacco intends to remain as the title sponsor, through LuckyStrike, for the 2006 season, but will honour its long-standing commitment toexit Formula One sponsorship at the end of that season. This is consistent withthe International Tobacco Marketing Standards, to which British American Tobaccovoluntarily subscribed in 2001, along with its major international competitors. Jimmi Rembiszewski, Director, Marketing commented: "It will be sad to end ourassociation but it is immensely satisfying to leave the team in the competenthands of Honda who are proven winners in the sport. We wish Honda every successfor the future and look forward to our last year of sponsorship." British American Tobacco was advised on this transaction by HSBC. ENQUIRIES British American Tobacco Press Office David Betteridge, Teresa La Thangue, Emily Brand +44 (0) 20 7845 2888 Notes to editors • The International Tobacco Product Marketing Standards are globallyapplicable and in some countries, exceed the requirements of local laws orvoluntary codes. British American Tobacco audits its companies' performanceagainst them annually, reports on this in its Social Report and promotesadoption of the Standards by competitors. • The full Standards are on www.bat.com: in Our Business / MarketingStandards. • Reporting on our companies' adherence to the Standards is in www.bat.com/ socialreport: Marketing and Youth Smoking Prevention. • Amongst other detailed points, the International Marketing Standardsstate that, from December 2006, there will be no sponsored events under atobacco product brand where the event may have a particular appeal to youth, mayreceive exposure other than as a news item and where success in the sponsoredactivity requires above average physical fitness. • The Standards also state that no advertisement shall feature a celebrityor suggest that sporting, popularity or professional success is enhanced bysmoking. An advertisement is defined as any communication to consumers whichhas the aim of encouraging them to select one brand of tobacco products overanother. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Mar 20242:20 pmRNSDirector/PDMR Shareholding
5th Mar 20244:30 pmRNSPublication of a Prospectus
4th Mar 20242:15 pmRNSDirector/PDMR Shareholding
1st Mar 202410:45 amRNSDirector/PDMR Shareholding
1st Mar 202410:40 amRNSTotal Voting Rights
21st Feb 202410:45 amRNSDirector/PDMR Shareholding
16th Feb 202411:30 amRNSPricing Notes Offering
15th Feb 20242:55 pmRNSDirector/PDMR Shareholding
13th Feb 20241:30 pmRNSPublication of Suppl.Prospcts
13th Feb 20249:55 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSAnnual Financial Report
8th Feb 202412:15 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
6th Feb 202410:10 amRNSDirector/PDMR Shareholding
6th Feb 202410:05 amRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSBoard and Committee Changes
5th Feb 202412:25 pmRNSDirector/PDMR Shareholding
5th Feb 202412:20 pmRNSDirector/PDMR Shareholding
5th Feb 202412:15 pmRNSDirector/PDMR Shareholding
2nd Feb 202412:00 pmRNSBAT and PMI Announce Global Patent Settlement
1st Feb 202412:45 pmRNSTotal Voting Rights
15th Jan 20242:00 pmRNSDirector/PDMR Shareholding
4th Jan 202412:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:10 amRNSBlock listing Interim Review
2nd Jan 202410:15 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSBranch Register: Dividend Finalisation Information
11th Dec 202310:35 amRNSHolding(s) in Company
11th Dec 202310:30 amRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
6th Dec 20237:55 amRNSPre-Close Trading Update and Strategy Update
6th Dec 20237:00 amRNSPre-Close Trading Update and Strategy Update
4th Dec 202311:30 amRNSTotal Voting Rights
4th Dec 20239:24 amRNSDirectorate Change
24th Nov 20232:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.